ah

Akso Health

AHG
NASDAQ
$0.85

How predictable is Akso Health's business?

Revenue visibility is low and the model has changed multiple times (P2P lending disposed in 2020, social e‑commerce disposed in 2023, COVID test kits ceased, pivot to insurance lead‑gen in 2024, nascent online hospital and proposed U.S. oncology services).

Concentration of customers and suppliers amplifies volatility, and PRC regulatory exposure adds unpredictability. The auditor included a going‑concern paragraph. This is the opposite of a toll‑booth or subscription‑like revenue stream.